Artificial Intelligence Platform for Precision Health

Artificial Intelligence Platform for Precision Health

LizAI innovates a cutting-edge AI platform that provides

life-changing solutions to millions of patients


LizAI Innovates A Cutting-Edge AI Platform That Provides Life-Changing Solutions To Millions Of Patients

About Us

LizAI Was Invented For Precision Health With An Ultimate Mission:

Providing Life-Changing Solutions To Patients

LizAI combines A diverse team of innovators, with solid expertise in sciences and technologies of precision health, including AI, big data, privacy-preserving, cloud APIs integration, pharmaceuticals, and clinical research.

Our technology disrupts the current AI models for healthcare by a superior innovative AI platform in its accuracy, speed, extendability, scalability, and security.

LizAI Platform

Integration of Cutting-Edge Sciences and Technologies

LizAI platform

AI Platform for Precision Health

LizAI Inc. develops a cutting-edge AI platform that is superior in accuracy, speed, extendability, scalability, and security.

Discover More

We share the market value of

0B
in 2022
0%
CAGR from 2022– 2030

LizAI’s Services

Our goal is to provide services to insurance companies, hospitals, pharmaceutical companies, and directly to users.

The significant burdens posed by Obese Diabetes (type II)

0B
in 2022
0%
US Population

LizAI first-Line Product

Provides solutions to the challenges in treating Obese Diabetes (type II), in which area LizAI Inc. is the pioneer.

40%

US population

Lives with a high risk of Obese Diabetes, posing a significant burden on the healthcare system. The total yearly cost for these patients is $327B in the US.

There are at least 60 approved medicines. Moreover, obese diabetes itself is multifactorial and complex, which in many cases leads to other health complications (e.g., cardiac diseases, stroke, liver and kidney diseases, cancers, etc.) and requires combined drugs treatment. This is thus significantly challenging for doctors to evaluate the patients’ condition and effectively provide multiple drugs prescription.

Additionally, according to clinical reports, many of the prescribed drugs do not work as expected and need to be re-defined for each patient’s needs. The drug-to-drug interaction has not been systematically recorded and deeply studied, posing high risks of disease complications. Precision treatment is thus urgently needed.